Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 857949 | ISIN: US9497461015 | Ticker-Symbol: NWT
Tradegate
24.01.25
18:25 Uhr
73,88 Euro
-0,45
-0,61 %
1-Jahres-Chart
WELLS FARGO & COMPANY Chart 1 Jahr
5-Tage-Chart
WELLS FARGO & COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
73,7473,9719:29
73,7473,9719:27
ACCESS Newswire
538 Leser
Artikel bewerten:
(2)

Wells Fargo IN(2) Welcomes New Cohort Focused on Decarbonization Solutions for Buildings

Finanznachrichten News

DENVER / ACCESSWIRE / November 20, 2024 / Wells Fargo

Three startups awarded $250,000 each in non-dilutive funding to accelerate energy-efficient, resilient building technologies

The Wells Fargo Innovation Incubator (IN²), a clean technology program funded by Wells Fargo and co-administered by the U.S. Department of Energy's National Renewable Energy Laboratory (NREL), today announced the selection of three startups for its next cohort in the Emerging Tech Track. This cohort targets scalable, drop-in solutions for the built environment to drive energy efficiency, reduce emissions, and support decarbonization across commercial and residential sectors.

"With increasing urbanization, addressing energy demands and building resilience is paramount," said Sarah Derdowski, IN² program manager at NREL. "These startups have market-ready technologies poised to make a meaningful impact on how we manage buildings' energy demands. Their solutions are designed for quick deployment across diverse settings, helping to accelerate adoption and maximize energy efficiency and sustainability."

Each company will receive $250,000 in non-dilutive funding and work closely with NREL's leading scientists and engineers to refine and validate their technologies. The startups were nominated by IN²'s Channel Partner network, which includes more than 60 business incubators, accelerators, and university programs across the United States.

The selected companies in IN²'s 14th cohort are:

  • Blip Energy (Chicago, Illinois): Focused on transforming the grid into a resource, Blip's smart battery platform manages the energy consumption of high load appliances like air conditioners, refrigerators, and more. This affordable drop-in technology makes an immediate impact without the typical barriers around permitting and installation. Blip Energy will collaborate with NREL's Dr. Ravi Kishore.

  • Evercloak (Waterloo, Ontario): Evercloak is revolutionizing how buildings are cooled with its refrigerant-free dehumidification systems, powered by graphene-oxide membrane technology. The solution can improve building cooling energy use by up to 50%. Evercloak will collaborate with NREL's Dr. Jason Woods.

  • Transaera (Somerville, Massachusetts): Transaera's advanced dehumidification system addresses the energy-intensive nature of air conditioning in humid climates. Their solution integrates with standard HVAC systems to reduce the energy consumption of commercial air conditioning by 40%. Transaera will collaborate with NREL's Dr. Nelson James.

These companies' innovations represent critical advancements toward IN²'s mission of enabling clean technology solutions that address real-world challenges. In addition to financial support, selected startups gain access to NREL's unparalleled research facilities and expertise, de-risking their technology in the lab and positioning them for continued market success.

"We're thrilled to continue our work with IN2 and support innovative companies working to address energy and resilience challenges in buildings," said Jeff Schub, senior vice president and leader of Sustainable Finance Integration and interim co-head of Sustainability at Wells Fargo. "We are particularly excited that this cohort will get real-time feedback from companies in IN2's new Scalable Tech Track. The demand for innovative solutions in the building and sustainability space is only growing, so we continue to support companies preparing to meet that rising need."

With the addition of this 14th cohort, IN²'s portfolio now totals 75 companies spanning sectors from agriculture and housing to the built environment. To date, the program's portfolio companies have collectively secured more than $2.6 billion in follow-on funding, reflecting IN²'s pivotal role in fostering technology that advances sustainability and resilience.

About the Wells Fargo Innovation Incubator (IN²)

The Wells Fargo Innovation Incubator (IN²) is a $50 million technology program funded by Wells Fargo and co-administered by the U.S. Department of Energy's National Renewable Energy Laboratory. IN² advances clean technologies from ideation to commercialization-validating emerging startups in the built environment and infrastructure sectors while facilitating connections with end users who receive practical implementation guidance that supports their sustainability goals. IN²'s mission is to foster innovation and accelerate the pace of market adoption of clean technologies to address urgent climate challenges. For more information, visit in2ecosystem.com.


View additional multimedia and more ESG storytelling from Wells Fargo on 3blmedia.com.

Contact Info:
Spokesperson: Wells Fargo
Website: https://www.3blmedia.com/profiles/wells-fargo
Email: info@3blmedia.com

SOURCE: Wells Fargo



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.